Allogene Therapeutics Inc (ALLO)
2.54
-0.03
(-1.17%)
USD |
NASDAQ |
Jun 13, 16:00
2.55
+0.01
(+0.39%)
After-Hours: 20:00
Allogene Therapeutics Price to Book Value: 1.149 for June 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 13, 2024 | 1.149 |
| June 12, 2024 | 1.163 |
| June 11, 2024 | 1.154 |
| June 10, 2024 | 1.104 |
| June 07, 2024 | 1.050 |
| June 06, 2024 | 1.091 |
| June 05, 2024 | 1.104 |
| June 04, 2024 | 1.054 |
| June 03, 2024 | 1.136 |
| May 31, 2024 | 1.131 |
| May 30, 2024 | 1.113 |
| May 29, 2024 | 1.054 |
| May 28, 2024 | 1.100 |
| May 24, 2024 | 1.140 |
| May 23, 2024 | 1.149 |
| May 22, 2024 | 1.204 |
| May 21, 2024 | 1.217 |
| May 20, 2024 | 1.172 |
| May 17, 2024 | 1.254 |
| May 16, 2024 | 1.362 |
| May 15, 2024 | 1.104 |
| May 14, 2024 | 1.096 |
| May 13, 2024 | 1.074 |
| May 10, 2024 | 1.022 |
| May 09, 2024 | 1.059 |
| Date | Value |
|---|---|
| May 08, 2024 | 1.021 |
| May 07, 2024 | 1.077 |
| May 06, 2024 | 1.114 |
| May 03, 2024 | 1.136 |
| May 02, 2024 | 1.099 |
| May 01, 2024 | 1.080 |
| April 30, 2024 | 1.021 |
| April 29, 2024 | 1.051 |
| April 26, 2024 | 1.069 |
| April 25, 2024 | 1.056 |
| April 24, 2024 | 1.125 |
| April 23, 2024 | 1.247 |
| April 22, 2024 | 1.258 |
| April 19, 2024 | 1.284 |
| April 18, 2024 | 1.280 |
| April 17, 2024 | 1.299 |
| April 16, 2024 | 1.293 |
| April 15, 2024 | 1.312 |
| April 12, 2024 | 1.404 |
| April 11, 2024 | 1.474 |
| April 10, 2024 | 1.504 |
| April 09, 2024 | 1.518 |
| April 08, 2024 | 1.470 |
| April 05, 2024 | 1.463 |
| April 04, 2024 | 1.496 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.658
Minimum
Nov 29 2023
11.17
Maximum
May 22 2020
3.060
Average
2.600
Median
Sep 12 2022
Price to Book Value Benchmarks
| ANI Pharmaceuticals Inc | 2.933 |
| Vaxart Inc | 2.382 |
| Agenus Inc | -- |
| BioCryst Pharmaceuticals Inc | -- |
| Stereotaxis Inc | 10.84 |
Price to Book Value Related Metrics
| PS Ratio | 6369.91 |
| Price | 2.54 |
| Earnings Yield | -71.65% |
| Market Cap | 530.31M |